SIGNAL-DRIVEN SALES

Turn Funding Signals into Pipeline

Fundz analyzes real-time funding events through YOUR lens to surface companies most likely to buy — with the “why now” built in.

10–25 ICP-matched leads daily • Buyer-intent scoring • No duplicates

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Slack + Chrome real-time alerts

✓No duplicates — only new events

INDUSTRY FIRST

Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership

Aug 26, 2020•about 5 years ago

Amount Raised

$4 Million

Round Type

series a

London

Description

Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ, bringing the company's total funding to CAD7.4 million. Anges Québec, AIoT Health, and health IT entrepreneur Sanjay Malaviya also participated in the oversubscribed round.

Company News

(10 articles)

Sat, 28 Jun 2025 07:00:00 GMT

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

Wed, 23 Jul 2025 07:00:00 GMT

White & Case advises joint lead managers on Hikma Pharmaceuticals’ US$500 million bond issuance - White & Case LLP

Mon, 30 Jun 2025 07:00:00 GMT

Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities - Contract Pharma

Wed, 02 Jul 2025 07:00:00 GMT

Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - PR Newswire

Mon, 23 Dec 2024 08:00:00 GMT

US FDA approves Hikma's generic version of Novo's diabetes drug Victoza - Reuters

Thu, 06 Feb 2025 08:00:00 GMT

White & Case advises Takeda on divestment of assets to Hikma and Esteve - White & Case LLP

Tue, 27 May 2025 07:00:00 GMT

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection - PR Newswire

Mon, 22 Jul 2024 07:00:00 GMT

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL, (10mg/mL) Bags Due to an Individual Unit of Acetaminophen Overwrap Found to Have Contained a Labelled Bag of Dexmedetomi - fda.gov

Tue, 24 Sep 2024 07:00:00 GMT